CASI Pharmaceuticals, Inc. Q2 Loss Widens

(RTTNews) - CASI Pharmaceuticals, Inc. (CASI) announced Loss for its second quarter that increased from last year

The company's earnings came in at -$10.24 million, or -$0.77 per share. This compares with -$7.68 million, or -$0.56 per share, in last year's second quarter.

The company's revenue for the quarter rose 14.6% to $9.82 million from $8.57 million last year.

CASI Pharmaceuticals, Inc. earnings at a glance (GAAP) :

-Earnings (Q2): -$10.24 Mln. vs. -$7.68 Mln. last year. -EPS (Q2): -$0.77 vs. -$0.56 last year. -Revenue (Q2): $9.82 Mln vs. $8.57 Mln last year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.